143 related articles for article (PubMed ID: 24634399)
1. Secondary malignant neoplasms after high-dose chemotherapy and autologous stem cell rescue for high-risk neuroblastoma.
Martin A; Schneiderman J; Helenowski IB; Morgan E; Dilley K; Danner-Koptik K; Hatahet M; Shimada H; Cohn SL; Kletzel M; Hijiya N
Pediatr Blood Cancer; 2014 Aug; 61(8):1350-6. PubMed ID: 24634399
[TBL] [Abstract][Full Text] [Related]
2. Secondary malignant neoplasms after intensive treatment of relapsed acute lymphoblastic leukaemia in childhood.
Borgmann A; Zinn C; Hartmann R; Herold R; Kaatsch P; Escherich G; Möricke A; Henze G; von Stackelberg A;
Eur J Cancer; 2008 Jan; 44(2):257-68. PubMed ID: 17981026
[TBL] [Abstract][Full Text] [Related]
3. High-risk neuroblastoma treated with tandem autologous peripheral-blood stem cell-supported transplantation: long-term survival update.
George RE; Li S; Medeiros-Nancarrow C; Neuberg D; Marcus K; Shamberger RC; Pulsipher M; Grupp SA; Diller L
J Clin Oncol; 2006 Jun; 24(18):2891-6. PubMed ID: 16782928
[TBL] [Abstract][Full Text] [Related]
4. Pediatric therapy-related myelodysplastic syndrome/acute myeloid leukemia: the MD Anderson Cancer Center experience.
Aguilera DG; Vaklavas C; Tsimberidou AM; Wen S; Medeiros LJ; Corey SJ
J Pediatr Hematol Oncol; 2009 Nov; 31(11):803-11. PubMed ID: 19801947
[TBL] [Abstract][Full Text] [Related]
5. Dexrazoxane-associated risk for acute myeloid leukemia/myelodysplastic syndrome and other secondary malignancies in pediatric Hodgkin's disease.
Tebbi CK; London WB; Friedman D; Villaluna D; De Alarcon PA; Constine LS; Mendenhall NP; Sposto R; Chauvenet A; Schwartz CL
J Clin Oncol; 2007 Feb; 25(5):493-500. PubMed ID: 17290056
[TBL] [Abstract][Full Text] [Related]
6. Secondary myeloid leukemia and myelodysplastic syndromes in patients treated for Hodgkin's disease: a report from the German Hodgkin's Lymphoma Study Group.
Josting A; Wiedenmann S; Franklin J; May M; Sieber M; Wolf J; Engert A; Diehl V;
J Clin Oncol; 2003 Sep; 21(18):3440-6. PubMed ID: 12668650
[TBL] [Abstract][Full Text] [Related]
7. Fractionated low-dose radiotherapy after myeloablative stem cell transplantation for local control in patients with high-risk neuroblastoma.
Bradfield SM; Douglas JG; Hawkins DS; Sanders JE; Park JR
Cancer; 2004 Mar; 100(6):1268-75. PubMed ID: 15022296
[TBL] [Abstract][Full Text] [Related]
8. A dose-intensive approach (NB96) for induction therapy utilizing sequential high-dose chemotherapy and stem cell rescue in high-risk neuroblastoma in children over 1 year of age.
Monnereau-Laborde S; Munzer C; Valteau-Couanet D; Ansoborlo S; Coze C; Chastagner P; Rubie H; Demeocq F; Stephan JL; Hartmann O; Perel Y
Pediatr Blood Cancer; 2011 Dec; 57(6):965-71. PubMed ID: 21744481
[TBL] [Abstract][Full Text] [Related]
9. High-dose BEAM chemotherapy with autologous haemopoietic stem cell transplantation for Hodgkin's disease is unlikely to be associated with a major increased risk of secondary MDS/AML.
Harrison CN; Gregory W; Hudson GV; Devereux S; Goldstone AH; Hancock B; Winfield D; MacMillan AK; Hoskin P; Newland AC; Milligan D; Linch DC
Br J Cancer; 1999 Oct; 81(3):476-83. PubMed ID: 10507773
[TBL] [Abstract][Full Text] [Related]
10. Second malignant neoplasms in long-term survivors of osteosarcoma: Memorial Sloan-Kettering Cancer Center Experience.
Aung L; Gorlick RG; Shi W; Thaler H; Shorter NA; Healey JH; Huvos AG; Meyers PA
Cancer; 2002 Oct; 95(8):1728-34. PubMed ID: 12365021
[TBL] [Abstract][Full Text] [Related]
11. Autologous stem cell transplantation for therapy-related acute myeloid leukemia and myelodysplastic syndrome.
Kröger N; Brand R; van Biezen A; Cahn JY; Slavin S; Blaise D; Sierra J; Zander A; Niederwieser D; de Witte T;
Bone Marrow Transplant; 2006 Jan; 37(2):183-9. PubMed ID: 16299545
[TBL] [Abstract][Full Text] [Related]
12. Second malignancy following high-dose therapy and autologous stem cell transplantation: incidence and risk factor analysis.
Forrest DL; Nevill TJ; Naiman SC; Le A; Brockington DA; Barnett MJ; Lavoie JC; Nantel SH; Song KW; Shepherd JD; Sutherland HJ; Toze CL; Davis JH; Hogge DE
Bone Marrow Transplant; 2003 Nov; 32(9):915-23. PubMed ID: 14561993
[TBL] [Abstract][Full Text] [Related]
13. Second malignancies in patients with neuroblastoma: the effects of risk-based therapy.
Applebaum MA; Henderson TO; Lee SM; Pinto N; Volchenboum SL; Cohn SL
Pediatr Blood Cancer; 2015 Jan; 62(1):128-33. PubMed ID: 25251613
[TBL] [Abstract][Full Text] [Related]
14. Characteristics and Outcomes of Second Malignant Neoplasms after Childhood Cancer Treatment: Multi-Center Retrospective Survey.
Koh KN; Yoo KH; Im HJ; Sung KW; Koo HH; Kim HS; Han JW; Yoon JH; Park HJ; Park BK; Baek HJ; Kook H; Lee JA; Lee JM; Lee KC; Kim SK; Park M; Lee YH; Lyu CJ; Seo JJ
J Korean Med Sci; 2016 Aug; 31(8):1254-61. PubMed ID: 27478336
[TBL] [Abstract][Full Text] [Related]
15. Neuroblastoma survivors are at increased risk for second malignancies: A report from the International Neuroblastoma Risk Group Project.
Applebaum MA; Vaksman Z; Lee SM; Hungate EA; Henderson TO; London WB; Pinto N; Volchenboum SL; Park JR; Naranjo A; Hero B; Pearson AD; Stranger BE; Cohn SL; Diskin SJ
Eur J Cancer; 2017 Feb; 72():177-185. PubMed ID: 28033528
[TBL] [Abstract][Full Text] [Related]
16. Improved survival of children with neuroblastoma between 1979 and 2005: a report of the Italian Neuroblastoma Registry.
Haupt R; Garaventa A; Gambini C; Parodi S; Cangemi G; Casale F; Viscardi E; Bianchi M; Prete A; Jenkner A; Luksch R; Di Cataldo A; Favre C; D'Angelo P; Zanazzo GA; Arcamone G; Izzi GC; Gigliotti AR; Pastore G; De Bernardi B
J Clin Oncol; 2010 May; 28(14):2331-8. PubMed ID: 20351331
[TBL] [Abstract][Full Text] [Related]
17. Secondary neoplasms after radiotherapy for a childhood solid tumor.
Paulino AC; Fowler BZ
Pediatr Hematol Oncol; 2005 Mar; 22(2):89-101. PubMed ID: 15804994
[TBL] [Abstract][Full Text] [Related]
18. Myeloablative megatherapy with autologous stem-cell rescue versus oral maintenance chemotherapy as consolidation treatment in patients with high-risk neuroblastoma: a randomised controlled trial.
Berthold F; Boos J; Burdach S; Erttmann R; Henze G; Hermann J; Klingebiel T; Kremens B; Schilling FH; Schrappe M; Simon T; Hero B
Lancet Oncol; 2005 Sep; 6(9):649-58. PubMed ID: 16129365
[TBL] [Abstract][Full Text] [Related]
19. Secondary or concomitant neoplasms among adults diagnosed with acute lymphoblastic leukemia and treated according to the LALA-87 and LALA-94 trials.
Tavernier E; Le QH; de Botton S; Dhédin N; Bulabois CE; Reman O; Vey N; Lhéritier V; Dombret H; Thomas X
Cancer; 2007 Dec; 110(12):2747-55. PubMed ID: 17963265
[TBL] [Abstract][Full Text] [Related]
20. Tandem high-dose chemotherapy and autologous stem cell rescue in patients over 1 year of age with stage 4 neuroblastoma.
Sung KW; Lee SH; Yoo KH; Jung HL; Cho EJ; Koo HH; Lee SK; Kim J; Lim DH; Suh YL; Kim DW
Bone Marrow Transplant; 2007 Jul; 40(1):37-45. PubMed ID: 17468771
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
